Polar Capital Healthcare Opports I Inc
Asset allocation %
Morningstar style box TM
Equity style
SizeLarge
Mid
Small
Value
Blend
Growth
Style
Size
| Share class size (mil) | 1,259 GBP (18/11/2026) |
| Fund size (mil) | 1,884 GBP (18/11/2026) |
Top 10 holdings
| Assets in top 10 holdings % | 54.85 |
| Total number of equity holdings | 33 |
| Total number of bond holdings | 0 |
| Holdings 30/09/2026 | % of assets |
|---|---|
| Eli Lilly and Co | 8.30 |
| Enliven Therapeutics Inc | 6.99 |
| Teva Pharmaceutical Industries Ltd | 6.47 |
| argenx SE | 6.12 |
| Novartis AG Registered Shares | 5.83 |
| Johnson & Johnson | 5.14 |
| Torrent Pharmaceuticals Ltd | 4.87 |
| Abbott Laboratories | 4.44 |
| Edwards Lifesciences Corp | 3.42 |
| Uniphar PLC | 3.27 |